Dr. Goodman on Ongoing Clinical Trials in Radiation Oncology

Karyn A. Goodman, MD
Published: Tuesday, Jan 05, 2016



Karyn A. Goodman, MD, radiation oncologist, professor in the Department of Radiation Oncology, University of Colorado Denver, discusses ongoing trials in the field of radiation oncology.

The RTOG 0848 study is a phase III trial examining chemoradiation as an adjuvant treatment for patients with resected head of pancreas adenocarcinoma, says Goodman, who is also the trial's radiation oncology principal investigator. Patients are randomized to receive chemoradiation after 6 months of gemcitabine. A second study, CALGB 80803, is a randomized phase II trial examining PET scan-directed combined modality therapy in patients with esophageal cancer.

Quality assurance for radiation is an area of unmet need required to better provide quality radiation care to patients, Goodman explains. She is also involved in evaluating US quality of care and reviewing cancer center radiation plans.

SELECTED
LANGUAGE


Karyn A. Goodman, MD, radiation oncologist, professor in the Department of Radiation Oncology, University of Colorado Denver, discusses ongoing trials in the field of radiation oncology.

The RTOG 0848 study is a phase III trial examining chemoradiation as an adjuvant treatment for patients with resected head of pancreas adenocarcinoma, says Goodman, who is also the trial's radiation oncology principal investigator. Patients are randomized to receive chemoradiation after 6 months of gemcitabine. A second study, CALGB 80803, is a randomized phase II trial examining PET scan-directed combined modality therapy in patients with esophageal cancer.

Quality assurance for radiation is an area of unmet need required to better provide quality radiation care to patients, Goodman explains. She is also involved in evaluating US quality of care and reviewing cancer center radiation plans.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Atlanta: Advances in the Treatment of Chronic Lymphocytic LeukemiaFeb 28, 20190.5
Community Practice Connections™: 2nd Annual International Congress on Immunotherapies in Cancer™: Focus on Practice-Changing ApplicationFeb 28, 20192.0
Publication Bottom Border
Border Publication
x